ALB and diabetic kidney disease: The results from the current study showed that APSAE reduces the development of diabetic nephropathy by increasing serum parameters such as albumin and total protein, but a reduction in serum creatinine and urea as well as urine albumin and total protein in treated rats as compared with diabetic control rats.